Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort

被引:15
|
作者
Dauby, Solene [1 ,2 ]
Dive, Dominique [1 ]
Lutteri, Laurence [4 ]
Andris, Cecile [3 ]
Hansen, Isabelle [1 ]
Maquet, Pierre [1 ,2 ]
Lommers, Emilie [1 ,2 ]
机构
[1] CHU Liege, Univ Hosp Liege, Clin Neuroimmunol Unit, Dept Neurol, Liege, Belgium
[2] Univ Liege, GIGA CRC Vivo Imaging, Liege, Belgium
[3] Univ Hosp Liege, Ophthalmol Dept, Clin Ophthalmol Unit, Liege, Belgium
[4] Univ Hosp Liege, Clin Chem Dept, Liege, Belgium
关键词
Neuromyelitis optica; MOG-associated disorders; AQP4-antibody NMO spectrum disorders; Optic neuritis; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; OPTICA SPECTRUM DISORDERS; NEUROMYELITIS-OPTICA; CLINICAL PRESENTATION; TREATMENT RESPONSES; IGG; ANTIBODY; NEURITIS; MULTICENTER; AQUAPORIN-4;
D O I
10.1007/s13760-021-01712-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To emphasize physio-pathological, clinical and prognosis differences between conditions causing serious and sometimes very similar clinical manifestations: anti-aquaporin-4 (AQP4) and anti-myelin oligodendrocyte glycoprotein (MOG) antibodies related diseases, and seronegative NMOSD (neuromyelitis optica spectrum disorders). Based on Wingerchuk et al. (Neurology 85:177-189, 2015) criteria for NMOSD and on those more recently proposed by Jarius et al. (J Neuroinflammation 15:134, 2018) for MOGAD (MOG associated disorders), we retrospectively surveyed 10 AQP4-NMOSD, 8 MOGAD and 2 seronegative NMOSD, followed at the specialized neuroimmunology unit of the CHU Liege. Female predominance was only observed in AQP4 group. Age at onset was 37.8 and 27.7 years old for AQP4-NMOSD and MOGAD, respectively. In both groups, the first clinical event most often consisted of optic neuritis (ON), followed by isolated myelitis. Fifteen of our 20 patients encountered a relapsing course with 90% relapses in AQP4-NMOSD, 62.5% in MOGAD and 50% in the seronegative group, and a mean period between the first and second clinical event of 7.1 and 4.8 months for AQP4-NMOSD and MOGAD, respectively. In total, we counted 54 ON, with more ON per patient in MOGAD. MOG-associated ON mainly affected the anterior part of the optic nerve with a papilledema in 79.2% of cases. Despite a fairly good visual outcome after MOG-associated ON, retinal nerve fibre layer (RNFL) thickness decreased, suggesting a fragility of the optic nerve toward further attacks. As observed in larger cohorts, our MOGAD and AQP4-NMOSD cases differ by clinical and prognostic features. A better understanding of these diseases should encourage prompt biological screening and hasten proper diagnosis and treatment.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 50 条
  • [41] Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience
    Rempe, Torge
    Tarhan, Bedirhan
    Rodriguez, Elsa
    Viswanathan, Vyas Tenkasi
    Gyang, Tirisham Victoria
    Carlson, Aaron
    Tuna, Ibrahim Sacit
    Rees, John
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
  • [42] Comparison of Clinical Features of Aquaporin-4 Positive Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein (MOG) Associated Disorder, and Seronegative NMOSD - A Single Center Experience
    Ozbek, Ezgi Demirel
    Cakan, Melike
    Acar, Nazire Pinar
    Colpak, Ayse Ilksen
    Kasikci, Merve
    Karabudak, Rana
    Tuncer, Meryem Asli
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 660 - 661
  • [43] A comparative study between the clinical characteristics of NMOSD & MOGAD related LETM versus Idiopathic Double Seronegative LETM in a tertiary care hospital in Eastern India
    Banik, Ankur
    Pal, Sandip
    Biswas, Debsadhan
    Ghosh, Srabani
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 709 - 709
  • [44] Distinct CSF complement activation pattern following C5 cleavage in MOGAD and AQP4-IgG+NMOSD
    Kaneko, Kimihiko
    Kuroda, Hiroshi
    Matsumoto, Yuki
    Sakamoto, Naohiro
    Yamazaki, Naoya
    Yamamoto, Naoki
    Umezawa, Shu
    Namatame, Chihiro
    Ono, Hirohiko
    Takai, Yoshiki
    Takahashi, Toshiyuki
    Fujimori, Juichi
    Nakashima, Ichiro
    Harigaya, Yasuo
    Fujihara, Kazuo
    Misu, Tatsuro
    Aoki, Masashi
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 134 - 135
  • [45] Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS
    Duan, Yunyun
    Zhuo, Zhizheng
    Li, Haiqing
    Tian, De-Cai
    Li, Yuxin
    Yang, Liqin
    Gao, Chenyang
    Zhang, Tian
    Zhang, Xinghu
    Shi, Fu-Dong
    Barkhof, Frederik
    Liu, Yaou
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (07): : 709 - 716
  • [46] Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD
    Hyun, Jae-Won
    Lee, Hye Lim
    Park, Jaehong
    Kim, Jiah
    Min, Ju-Hong
    Kim, Byoung Joon
    Kim, Seung Woo
    Shin, Ha Young
    Huh, So-Young
    Kim, Woojun
    Seo, Ji Won
    Kim, Ki Hoon
    Kim, Su-Hyun
    Kim, Ho Jin
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (06) : 989 - 992
  • [47] Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD
    Dinoto, Alessandro
    Sechi, Elia
    Ferrari, Sergio
    Gajofatto, Alberto
    Orlandi, Riccardo
    Solla, Paolo
    Maccabeo, Alessandra
    Maniscalco, Giorgia Teresa
    Andreone, Vincenzo
    Sartori, Arianna
    Manganotti, Paolo
    Rasia, Sarah
    Capra, Ruggero
    Mancinelli, Chiara Rosa
    Mariotto, Sara
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 58
  • [48] Common and distinct associations of HLA-DRB1 and-DPB1 alleles with anti-AQP4 antibody-seropositive NMO/NMOSD, -seronegative NMO/NMOSD, and non-NMO/NMOSD MS in Japanese
    Yoshimura, S.
    Matsushita, T.
    Isobe, N.
    Yonekawa, T.
    Masaki, K.
    Kira, J-I.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S110 - S111
  • [49] Frequency, characteristics and outcomes of myelin oligodendrocyte glycoprotein-antibody-associated-disorder (MOGAD) and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder (AQP4-NMOSD) attacks requiring ventilatory support
    Zhao-Fleming, H.
    Sanchez, C. V.
    Sechi, E.
    Inbarasu, J.
    Wijdicks, E. F.
    Pittock, S. J.
    Chen, J. J.
    Wingerchuk, D. M.
    Weinshenker, B. G.
    Lopez-Chiriboga, S.
    Dubey, D.
    Toledano, M.
    Yadav, H.
    Flanagan, E. P.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 13 - 14
  • [50] Asymptomatic spinal lesions in patients with AQP4-IgG-positive NMOSD: A real-world cohort study
    Cao, Shugang
    Zhu, Yunfei
    Wu, Xiaosan
    Du, Jing
    Xu, Si
    Cui, Ping
    Li, Qi
    Xia, Mingwu
    Xue, Qun
    Tian, Yanghua
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (04): : 905 - 915